Skip to main content
HUALAN GROUP CO.,LTD. logo

HUALAN GROUP CO.,LTD. — Investor Relations & Filings

Ticker · 301027 ISIN · CNE100004MH7 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 662 across all filing types
Latest filing 2023-04-24 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 301027

About HUALAN GROUP CO.,LTD.

https://www.gxhl.com

Hualan Group Co., Ltd. specializes in the research, development, and manufacturing of primary pharmaceutical packaging materials. The company's core product portfolio includes high-quality butyl rubber stoppers, aluminum-plastic combination caps, and plastic components designed for injectable medications and infusion sets. These products are engineered to ensure drug stability and compatibility, meeting international quality standards such as GMP. Serving a global clientele of pharmaceutical manufacturers, the group focuses on advanced material science and precision manufacturing to provide secure sealing solutions for vaccines, antibiotics, and blood products. By integrating R&D with large-scale production capabilities, the company maintains a significant role in the pharmaceutical supply chain, emphasizing safety and reliability in drug delivery systems.

Recent filings

Filing Released Lang Actions
公司章程（2023年4月）
Governance Information Classification · 100% confidence The document is a detailed company charter (章程) for 华蓝集团股份公司 (Hualan Group Co., Ltd.), including sections on general provisions, business scope, shares issuance, shareholding structure, shareholders' rights and obligations, board of directors, management, supervisory board, financial accounting system, profit distribution, audit, notices and announcements, mergers, capital changes, dissolution, and amendments to the charter. It references Chinese laws and regulatory bodies such as the China Securities Regulatory Commission (中国证监会) and Shenzhen Stock Exchange rules. The content is focused on governance structure, shareholder rights, board responsibilities, and company operational rules rather than financial results or earnings. It is a governance document detailing the company's internal rules and governance practices. The document length is substantial (15,000 characters), indicating it is the full charter text, not a brief announcement or summary. Therefore, the appropriate classification is Governance Information (CGR).
2023-04-24 Chinese
天职业字[2023]18286-1号 募集资金存放与使用情况鉴证报告
Audit Report / Information Classification · 95% confidence The document is titled as a "2022年度募集资金存放与使用情况鉴证报告" which translates to "2022 Annual Fundraising Funds Deposit and Usage Verification Report." It is issued by a certified public accountant firm and includes an audit opinion on the company's use and management of funds raised through a public offering. The document references regulatory guidelines from the China Securities Regulatory Commission and Shenzhen Stock Exchange regarding fundraising management and usage. It contains detailed financial data on the amount raised, usage, balances, and compliance with regulations. The document is a standalone audit verification report focused on the use of raised capital, not a full annual report or earnings release. It is not merely an announcement or certification but contains substantive financial and compliance information. Therefore, it fits the category of an Audit Report / Information (AR). FY 2022
2023-04-24 Chinese
关于公司2023年度日常关联交易预计的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from 华蓝集团股份公司 regarding the company's expected related party transactions for the year 2023. It includes details about the nature, amounts, and pricing principles of these transactions, as well as opinions from independent directors and the sponsor institution. The document is dated April 25, 2023, and focuses on disclosures about related party transactions, which is a regulatory disclosure requirement. It does not contain financial statements or comprehensive financial performance data, nor is it a full annual or interim report. It is not a voting result, management change, or earnings release. The document is a regulatory announcement about related party transactions, fitting best under Regulatory Filings (RNS). The document length (7,876 characters) and content confirm it is a detailed regulatory announcement rather than a full report or a brief notice.
2023-04-24 Chinese
关于2023年一季度计提减值准备的公告
Regulatory Filings Classification · 90% confidence The document is an announcement from 华蓝集团股份公司 regarding the impairment provision for the first quarter of 2023. It details the amount of impairment provision, the accounting methods used, and the impact on the company's profit. The document is relatively short (1867 characters) and does not contain full financial statements or comprehensive financial analysis. It is a specific announcement about an accounting estimate adjustment rather than a full quarterly or annual report. It also does not appear to be a certification or a regulatory compliance filing. Therefore, it fits best as a Regulatory Filing (RNS) because it is a specific disclosure about accounting estimates and provisions without the full financial report context.
2023-04-24 Chinese
2023年一季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "华蓝集团股份公司2023 年第一季度报告" which translates to "Hualan Group Co., Ltd. 2023 First Quarter Report." It contains detailed financial data including balance sheets, profit and loss statements, cash flow statements, and explanations of financial metrics for the first quarter of 2023. The document explicitly states it is a quarterly report and includes comprehensive financial statements and analysis for a period shorter than a full fiscal year. It also mentions that the report is unaudited, which is typical for interim or quarterly reports. The length of the document (12,262 characters) and the detailed financial content confirm it is the actual report, not just an announcement or summary. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). Q1 2023
2023-04-24 Chinese
2022年度董事会工作报告
Board/Management Information Classification · 95% confidence The document is titled '2022 年度董事会工作报告' which translates to '2022 Annual Board of Directors Work Report'. It details the board's activities, including company performance, governance, meetings held, and plans for the next year. It includes financial performance summaries, descriptions of board meetings, committees, and governance practices. The document is comprehensive and contains substantive information about the board's work over the year, not just an announcement or summary. It is not a full annual report (10-K) but specifically a detailed board/management information report focusing on the board's work and governance. Therefore, the most appropriate classification is 'Board/Management Information' (MANG). The document length (7303 characters) supports it being a full report rather than a brief announcement.
2023-04-24 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.